164 related articles for article (PubMed ID: 10936322)
1. Costimulatory signal blockade by anti-CD2 monoclonal antibody in combination with 15-deoxyspergualin prolongs concordant xenograft survival.
Haga M; Hirahara H; Tsuchida M; Watanabe T; Takekubo M; Hayashi J
Transplant Proc; 2000 Aug; 32(5):1006-8. PubMed ID: 10936322
[No Abstract] [Full Text] [Related]
2. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
[No Abstract] [Full Text] [Related]
3. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation.
Kemp E; Dieperink H; Leth P; Jensenius JC; Nielsen B; Lillevang ST; Salomon S; Steinbrüchel D; Larsen S; Koch C
Transplant Proc; 1994 Apr; 26(2):1011-5. PubMed ID: 8171451
[No Abstract] [Full Text] [Related]
4. Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts.
Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H
Transplant Proc; 1993 Feb; 25(1 Pt 1):405-6. PubMed ID: 8438355
[No Abstract] [Full Text] [Related]
5. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478
[No Abstract] [Full Text] [Related]
6. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
[No Abstract] [Full Text] [Related]
7. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of corneal xenograft survival with deoxyspergualin and anti-LFA-1 monoclonal antibody.
Yamagami S; Isobe M; Yamagami H; Hori J; Kaburaki T; Tsuru T
Transplant Proc; 1997 Jun; 29(4):2288-9. PubMed ID: 9193626
[No Abstract] [Full Text] [Related]
9. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
[No Abstract] [Full Text] [Related]
10. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
[TBL] [Abstract][Full Text] [Related]
11. Targeting additional costimulatory pathways: a subtle role for CD2.
Dumont C; Deas O; Hebib C; Durrbach A; Hirsch F; Charpentier B; Senik A
Transplant Proc; 2001; 33(1-2):199-200. PubMed ID: 11266778
[No Abstract] [Full Text] [Related]
12. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Pruitt SK; Halperin EC; Bollinger RR
Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
[No Abstract] [Full Text] [Related]
13. Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.
Fukuzaki T; Gotoh M; Hasuike Y; Tanigawa T; Nagano H; Umeshita K; Kanai T; Monden M; Mori T
Transplant Proc; 1994 Apr; 26(2):779. PubMed ID: 7513472
[No Abstract] [Full Text] [Related]
14. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
[No Abstract] [Full Text] [Related]
15. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
16. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495
[No Abstract] [Full Text] [Related]
17. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation.
Thomas F; Araneda D; Quarantillo P
Transplant Proc; 1994 Jun; 26(3):1220-3. PubMed ID: 8029894
[No Abstract] [Full Text] [Related]
18. Synergistic effects of 15-deoxyspergualin with cyclosporine and the TCR-targeted monoclonal antibody R73 to induce specific unresponsiveness to skin allografts in rats.
Schorlemmer HU; Dickneite G; Kurrle R; Seiler FR
Transplant Proc; 1995 Feb; 27(1):414-6. PubMed ID: 7879044
[No Abstract] [Full Text] [Related]
19. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
20. Simple therapy for cardiac concordant xenotransplantation: only 1 week of DSG administration with suppression of t-cell reactions.
Kubota S; Miyatake T; Miyazaki K; Watanabe T; Mafune N; Watanabe S; Abe K; Murashita T; Yasuda K
Transplant Proc; 2000 Aug; 32(5):1020. PubMed ID: 10936329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
